Article
Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations.
Blood - 1 Dec 2005
Döhner Konstanze, Schlenk Richard F, Habdank Marianne, Scholl Claudia, Rücker Frank G, Corbacioglu Andrea, Bullinger Lars, Fröhling Stefan, Döhner Hartmut
Abstract excerpt
To assess the prognostic relevance of mutations in the NPM1 gene encoding a nucleocytoplasmic shuttle protein in younger adults with acute myeloid leukemia (AML) and normal cytogenetics, sequencing of NPM1 exon 12 was performed in diagnostic samples from 300 patients entered into 2 consecutive multicenter trials of the AML Study Group (AMLSG). Treatment included intensive double-induction therapy and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
